TGF-{beta} antagonists as mitigators of radiation-induced tissue damage
Patent
·
OSTI ID:462854
A method for treating tissue damage caused by radiation is described by use of a TGF-{beta} antagonist, such as an anti-TGF-{beta} antibody or a TGF-{beta} latency associated protein. It is administered not more than a week after exposure, and is particularly useful in mitigating the side effects of breast cancer therapy.
- Research Organization:
- Univ. of California (United States)
- DOE Contract Number:
- AC03-76SF00098
- Assignee:
- Univ. of California, Oakland, CA (United States)
- Patent Number(s):
- US 5,616,561/A/
- Application Number:
- PAN: 8-414,020; TRN: 97:007360
- OSTI ID:
- 462854
- Resource Relation:
- Other Information: PBD: 1 Apr 1997
- Country of Publication:
- United States
- Language:
- English
Similar Records
TGF-.beta. antagonists as mitigators of radiation-induced tissue damage
Antitransforming growth factor-{beta} antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation
Transplantation of periaortic adipose tissue inhibits atherosclerosis in apoE −/− mice by evoking TGF-β1-mediated anti-inflammatory response in transplanted graft
Patent
·
Wed Jan 01 00:00:00 EST 1997
·
OSTI ID:462854
Antitransforming growth factor-{beta} antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation
Journal Article
·
Sat Jul 01 00:00:00 EDT 2006
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:462854
+2 more
Transplantation of periaortic adipose tissue inhibits atherosclerosis in apoE −/− mice by evoking TGF-β1-mediated anti-inflammatory response in transplanted graft
Journal Article
·
Fri Jun 15 00:00:00 EDT 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:462854
+3 more